Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract
infections in infants and young children, accounting for more than 100,000 hospitalizations …

Respiratory Syncytial Virus (RSV) is a common virus that infects children and adults;
however, children younger than two years of age tend to develop more serious respiratory …

Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants,
young children, and older or immunocompromised adults. Although aerosolized ribavirin …

Abstract Introduction The REGAL (RSV Evidence–A Geographical Archive of the Literature)
series has provided a comprehensive review of the published evidence in the field of …

Respiratory syncytial virus (RSV) is an important respiratory pathogen in infants and children
worldwide. Although RSV typically causes mild upper respiratory infections, it frequently …

Respiratory syncytial virus (RSV) infects almost all children by two years of age, resulting in
a large number of hospital admissions in infants. Reactive airway disease is more common …

Respiratory syncytial virus (RSV) remains a significant cause of morbidity and mortality in
infants, immunocompromised patients and the elderly. Despite the high disease burden, an …

Respiratory syncytial virus (RSV) infection is ubiquitous with almost all infants having been
infected by 2 years of age and lifelong repeated infections common. It is the second largest …

Respiratory syncytial virus (RSV) infection is a leading cause of hospitalisation in early
childhood and palivizumab is the only licensed intervention for prevention. Palivizumab …

Respiratory syncytial virus (RSV) infection is a significant cause of hospitalization of children
in North America and one of the leading causes of death of infants less than 1 year of age …